Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2018-06-28Clinical Trial Update: Detecting the Influence of Cataract Surgery on the Development of Diabetic Retinopathy in Patients With Diabetes Mellitus Type 2 With and Without Diabetic Retinopathy Using OCT Angiography
This clinical trial from Cairo University investigates whether cataract surgery influences the development of diabetic retinopathy in people…
-
CLINICAL_TRIALS research · 2018-06-27Clinical Trial Update: Vascular and Metabolic Changes in Postmenopausal Diabetics
A clinical trial update examining vascular and metabolic changes in postmenopausal individuals with type 2 diabetes; current status is unkno…
-
CLINICAL_TRIALS research · 2018-06-26Clinical Trial Update: Nanshan Elderly Cohort Study
The Nanshan Elderly Cohort Study, sponsored by Sun Yat-sen University, is currently recruiting. The study focuses on older adults with hyper…
-
CLINICAL_TRIALS trial_result · 2018-06-25Clinical Trial Update: Safety, Tolerability and Efficacy of ISIS-GCGRRx in Patients With Type 2 Diabetes [Phase 2]
Phase 2 trial evaluating the safety, tolerability and efficacy of ISIS-GCGRRx in adults with Type 2 diabetes has completed.
-
CLINICAL_TRIALS trial_result · 2018-06-25Clinical Trial Update: A Trial Comparing the Efficacy and Safety of Liraglutide 1.8 mg/Day to Liraglutide 0.9 mg/Day in Japanese Subjects With Type 2 Diabetes Mellitus. [Phase 3]
Phase 3 trial comparing higher vs. lower dose liraglutide in Japanese patients with type 2 diabetes; results posted in 2018.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-06-21Clinical Trial Update: MASTERMIND - Understanding Individual Variation in Treatment Response in Type 2 Diabetes [Phase 4]
MASTERMIND is a Phase 4 study investigating why individuals with Type 2 diabetes mellitus respond differently to therapies; the update notes…
-
CLINICAL_TRIALS research · 2018-06-21Clinical Trial Update: Gemigliptin, Dapagliflozin, Empagliflozin DDI Study [Phase 1]
Phase 1 clinical trial update evaluating drug-drug interactions among gemigliptin, dapagliflozin, and empagliflozin in type 2 diabetes melli…
-
CLINICAL_TRIALS trial_result · 2018-06-20Clinical Trial Update: Efficacy and Safety of Vildagliptin Added to Continuous Subcutaneous Insulin Infusion in Uncontrolled Type 2 Diabetes [Phase 4]
Phase 4 clinical trial evaluating the efficacy and safety of adding vildagliptin to continuous subcutaneous insulin infusion in adults with …
-
CLINICAL_TRIALS trial_result · 2018-06-20Clinical Trial Update: Daily Use of JARDIANCE® Tablets in Japanese Elderly Patients With Type 2 Diabetes Mellitus
A completed clinical trial update evaluating daily use of JARDIANCE tablets in elderly Japanese patients with type 2 diabetes mellitus; resu…
-
CLINICAL_TRIALS trial_result · 2018-06-20Clinical Trial Update: Saxagliptin in Combination With Dapagliflozin - Effects on Islet Cell Function [Phase 4]
Phase 4 clinical trial update evaluating the effects of combining saxagliptin with dapagliflozin on islet cell function in adults with type …
-
CLINICAL_TRIALS trial_result · 2018-06-20Clinical Trial Update: Development of Structured Exercise Program for T2DM Management [NA]
Completed clinical trial evaluating a structured exercise program, including high‑intensity interval training and resistance training, for m…
-
CLINICAL_TRIALS research · 2018-06-19Clinical Trial Update: Tai Chi Quan Improving Biochemistry and Quality of Life in Type 2 Diabetes [NA]
Clinical trial update on Tai Chi Quan examining biochemistry and quality of life in Type 2 Diabetes Mellitus. The sponsor is Taipei City Hos…
-
FDA approval · 2018-06-18FDA Approved: NATEGLINIDE — Original Application (Rising Pharma Holdings, Inc.)
FDA approved the original application for a generic version of nateglinide, manufactured by Rising Pharma Holdings, Inc.
-
CLINICAL_TRIALS trial_result · 2018-06-15Clinical Trial Update: Multiple Ascending Dose Study in Healthy Male Subjects and Overweight to Obese Male and Female Type 2 Diabetes Mellitus (T2DM) Patients [Phase 1]
A Phase 1 multiple ascending dose study evaluated healthy male volunteers and overweight to obese male and female patients with Type 2 Diabe…
-
CLINICAL_TRIALS trial_result · 2018-06-14Clinical Trial Update: Effect of Bydureon on Carotid Atherosclerosis Progression in Type 2 Diabetes Mellitus [Phase 4]
A Phase 4 clinical trial is evaluating whether Bydureon (exenatide extended-release) affects progression of carotid atherosclerosis in adult…
-
CLINICAL_TRIALS trial_result · 2018-06-13Clinical Trial Update: Impact of OCT1 on Metformin Tolerance [Phase 4]
Phase 4 study examining how OCT1 transport influences metformin tolerability. The trial status is completed.
-
CLINICAL_TRIALS research · 2018-06-13Clinical Trial Update: Umbrella Review and Updated Systematic Review and Meta-analysis of Pulses/Legumes and Incident Cardiometabolic Diseases
This umbrella review and updated systematic review and meta-analysis evaluates the relationship between pulses/legumes intake and incident c…
-
CLINICAL_TRIALS trial_result · 2018-06-12Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Cyclo-Z in Patients With Obese Type 2 Diabetes [Phase 2]
A Phase 2 study evaluated the efficacy and safety of Cyclo-Z in obese adults with Type 2 diabetes. The trial has completed and results were …
-
CLINICAL_TRIALS trial_result · 2018-06-12Clinical Trial Update: Effects of Dietary Fiber on Glucose Control in Subjects With Type 2 Diabetes Mellitus [Phase 4]
A Phase 4 clinical trial assessing the effect of dietary fiber on glucose control in adults with Type 2 diabetes mellitus has completed.
-
CLINICAL_TRIALS trial_result · 2018-06-11Clinical Trial Update: The Clinical Study to Assess the Effect of the Amount of Carbohydrate Intake and Meals Differing in Glycemic Index (GI) in Patients Treated With a Sodium-dependent Glucose Cotransporter 2 (SGLT2) Inhibitor [NA]
A completed clinical trial evaluated whether carbohydrate intake and meals with different glycemic index affect outcomes in patients with ty…
-
CLINICAL_TRIALS trial_result · 2018-06-08Clinical Trial Update: A Study for Patients With Type 2 Diabetes [Phase 2]
Phase 2 clinical trial update for Type 2 diabetes; results were posted in 2018 for a Lilly-sponsored study.
-
CLINICAL_TRIALS trial_result · 2018-06-06Clinical Trial Update: Effects of Eicosapentaenoic Acid on Endothelial Function in Diabetic Subjects [Phase 3]
A Phase 3 trial evaluating the effects of eicosapentaenoic acid on endothelial function in adults with type 2 diabetes and coronary artery d…
-
CLINICAL_TRIALS trial_result · 2018-06-04Clinical Trial Update: Are Audiovisual Materials Superior to Printed Materials in Improving Awareness Among Type 2 Diabetic Patients? [NA]
A completed clinical trial evaluating whether audiovisual materials improve awareness among people with Type 2 diabetes compared with printe…
-
FDA approval · 2018-06-01FDA Approved: NOVOLIN N — Supplemental Application (Novo Nordisk)
The FDA approved a supplemental application for NOVOLIN N (human insulin) submitted by Novo Nordisk.
-
FDA approval · 2018-06-01FDA Approved: NOVOLIN R — Supplemental Application (Novo Nordisk)
The FDA approved a supplemental application for NOVOLIN R (human insulin) from Novo Nordisk.